Invesco制药业ETF PJP 深 沪
等待开盘 06-11 09:30:00 美东时间
111.7691
-0.231
-0.21%
华盛通- 最 高113.20
- 今 开112.02
- 成交量 2.32万股
- 最 低 111.50
- 昨 收 112.00
- 总市值 3.48亿
- 52周最高 113.20
- 市盈率 静 --
- 换手率 0.75%
- 52周最低 77.9784
- 委 比 62.07%
- 总股本 311.00万
- 历史最高 113.20
- 量 比 1.49
- 振 幅 1.52%
- 历史最低 33.5584
- 每 手 1
- 风险率 9.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Amgen Posts 77% Response In Thyroid Eye Disease Study
Amgen shares fall despite Phase 3 TEPEZZA OBI data showing 77% response rate and proptosis reduction in thyroid eye disease patients.
04-06 22:57
Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial
Pfizer's Braftovi combo improves survival in advanced colorectal cancer trial.
02-17 23:15
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
Trump's "Great Healthcare Plan" targets PBM kickbacks to cut costs. Experts confirm these fees act as an industry "vig" driving up prices.
01-16 15:30
Will valuations see a floor? – Morgan Stanley’s Mike Wilson
If nominal GDP and earnings growth accelerate due to higher inflation, stocks’ valuation may see a support ahead, according to Michael J. Wilson, chief U.S. equity strategist and chief investment offi...
2025-10-07 00:51
Pharma stocks at 15-year valuation lows may offer value – BMO’s Evan Seigerman
Drug pricing policy clarity from the Trump administration could signal a turning point for pharmaceutical stocks (PPH), (PJP), (NYSEARCA:XPH), which have been among the worst performers this year with...
2025-10-02 02:51
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers.
2025-09-29 15:20
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices.
2025-09-08 13:49
Pullback presents buying opportunities as market will resume higher – PNC’s Yung-Yu Ma
PNC asset management chief investment strategist Yung-Yu Ma believes market pullbacks present buying opportunities despite growing concerns about weakening labor trends, as the market initially reacte...
2025-09-06 00:02
Citi’s Drew Pettit: Stocks are seeing a ‘healthy reset,’ not cause for concern
Citigroup’s director of U.S. equity strategy Drew Pettit described recent market declines as a “healthy reset” rather than a reason for alarm. In an interview with CNBC, Pettit emphasized that despite...
2025-09-03 03:38
Morgan Stanley’s Mike Wilson: Healthcare could rebound amid near record low valuations
Healthcare’s (NYSEARCA:XLV) market cap weight in the S&P 500 (SP500) and its relative forward P/E ratio are hovering around historical lows, but several factors could trigger a sentiment improvement, ...
2025-09-02 23:15
